Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study
Fabienne Charbit‐Henrion(Hôpital Necker-Enfants Malades), Nadine Cerf–Bensussan(Université Paris Cité), Emmanuel Mas(Université Toulouse III - Paul Sabatier), Sylvain Hanein(Inserm), M. Ben Hariz(Hôpital Mongi Slim), A. Dabadie(Centre Hospitalier Universitaire de Rennes), E Lévy(Délégation Paris 5), Jan Krzysztof Nowak(Poznan University of Medical Sciences), Jorge Amil Dias(Hospital de São João), Cécile Fourrage(Délégation Paris 5), Marina Aloi(Sapienza University of Rome), Bernadette Bègue(Délégation Paris 5), Yago González‐Lama(Hospital Universitario Puerta de Hierro Majadahonda), Alain Fischer(Inserm), Rémi Duclaux‐Loras(Hôpital Necker-Enfants Malades), Christian Breuer(University Medical Center Hamburg-Eppendorf), Julie Bruneau(Délégation Paris 5), Aude Fischer(Délégation Paris 5), Christelle Lenoir(Délégation Paris 5), Olivier Alibeu(Délégation Paris 5), Graziella Guariso(University of Padua), Jiří Bronský(Charles University), Fernando Magro(Universidade do Porto), Ödül Eğritaş Gürkan(Gazi University), Evi Karanika(424 General Military Hospital), Capucine Pïcard(Délégation Paris 5), Marta Díaz-Navarro(Hospital Universitario 12 De Octubre), János Major(Bethesda Gyermekkórház), Rosa Lima, Sabine Rakotobé(Délégation Paris 5), Clémentine Dumant‐Forest(Hôpital Charles-Nicolle), Jean‐Pierre Hugot(Institut de Systématique, Évolution, Biodiversité), Olivier Goulet(Hôpital Necker-Enfants Malades), Stephan Buderus(Hebrew University of Jerusalem), Sylvain Latour(Institut des Maladies Génétiques Imagine), Alain Lachaux(Hôpital Femme Mère Enfant), Georgia Malamut(Inserm), Matjaž Homan(University of Ljubljana), Frédéric Rieux‐Laucat(Inserm), Peter Lewindon(The University of Queensland), Éric Jeziorski(Centre Hospitalier Universitaire de Montpellier), Stéphanie Coopman(Hôpital Jeanne de Flandre), Mara Cananzi(University of Padua), Neslihan Gurcan(Gazi University), Alexandre Fabre(Hôpital de la Timone), Anne Breton(Centre Hospitalier Universitaire de Toulouse), Anne Bourrier(Sorbonne Université), Marie‐Claude Stolzenberg(Délégation Paris 5), Clara Crémilleux(Centre Hospitalier Universitaire de Saint-Étienne), Fabienne Mazerolles(Délégation Paris 5), Marianna Parlato(Université Paris Cité)
Cited by 91
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k